{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.095, "exchange": "FRA", "shortName": "BIOSERGEN AB", "longName": "Biosergen AB", "messageBoardId": "finmb_29019853", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketTime": 1683875702, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.05, "sharesOutstanding": 42427700, "fiftyDayAverage": 0.10344, "fiftyDayAverageChange": -0.008440003, "fiftyDayAverageChangePercent": -0.08159322, "twoHundredDayAverage": 0.20968619, "twoHundredDayAverageChange": -0.11468619, "twoHundredDayAverageChangePercent": -0.54694206, "marketCap": 4277432, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1625119200000, "priceHint": 4, "regularMarketChange": 0.0, "regularMarketDayHigh": 0.095, "regularMarketDayRange": "0.095 - 0.095", "regularMarketDayLow": 0.095, "regularMarketVolume": 70, "regularMarketPreviousClose": 0.095, "bid": 0.0, "ask": 0.0, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.095, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.012000002, "fiftyTwoWeekLowChangePercent": 0.14457834, "fiftyTwoWeekRange": "0.083 - 0.547", "fiftyTwoWeekHighChange": -0.452, "fiftyTwoWeekHighChangePercent": -0.8263254, "fiftyTwoWeekLow": 0.083, "fiftyTwoWeekHigh": 0.547, "symbol": "8N1.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Fogdevreten 2", "city": "Solna", "zip": "171 65", "country": "Sweden", "phone": "46 4 52 08 02 470", "website": "https://biosergen.net", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Biosergen AB, a biopharmaceutical company, engages in the development of antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of life threatening invasive fungal diseases. The company was founded in 2004 and is headquartered in Solna, Sweden.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Dr. Peder Moller Andersen", "age": 70, "title": "Chief Exec. Officer", "yearBorn": 1952, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Niels  Laursen M.B.A.", "age": 66, "title": "Chief Financial Officer", "yearBorn": 1956, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Tine Kold Olesen Ph.D.", "title": "Chief Operation Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Sergey B. Zotchev Ph.D.", "title": "Chief Scientific Officer and Member of Scientific Advisory Panel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}